Skip to main content

How long does it take for Skyrizi to work?

Medically reviewed by Melisa Puckey, BPharm. Last updated on Aug 1, 2024.

Official Answer by Drugs.com

Skyrizi (risankizumab-rzaa) is an injection given under the skin (subcutaneous injection) to treat patients who have moderate or severe plaque psoriasis (raised, silvery flaking of the skin) and for active psoriatic arthritis (PsA) which is a systemic inflammatory disease which affects the skin and joints.

How long does it take for Skyrizi to work for Psoriasis?

First of all, how do you measure improvement in psoriasis?

Data from the LIMMitless phase 3 study looked at the percentage of psoriasis patients who achieved 90% improvement in their PASI score (PASI 90) and results showed that Skryrizi starts working:

How long does it take for Skyrizi to work for psoriatic arthritis?

Improvements in psoriatic arthritis are measured by American College of Rhematology (ACR) Criteria which is a combined score of the number of tender joints, the number of swollen joints and also includes three of the following five criteria:

An ACR20 is when there is a 20% improvement in tender or swollen joint counts, as well as a 20% improvement in at least three of the other five above criteria.

The phase 3 KEEPsAKE 1 trial showed how long it took for Skyrizi to improve psoriatic arthritis. The results of the study showed the number of Skyrizi patients who had a 20% improvement (ACR20) in their psoriatic arthritis, compared to placebo patients.

The percentage of patients that achieved a 20% improvement in psoriatic arthritis:

Related questions

How long does it take for Skyrizi to work for Crohn’s disease?

For Crohn’s disease Skyrizi starts to have a significant clinical response in as early as 4 weeks. A clinical response for Crohn’s disease is defined as a 100-point reduction in Crohn's Disease Activity Index [CDAI] ).
After 12 weeks 23% more Skyrizi patients clinical response to Skyrizi compared to placebo patients (Skyrizi 60% - placebo 37%= 23%)

Bottom Line:

References
  • Risankizumab for psoriasis [Accessed February 3, 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186275/
  • PASI score DermNet NZ [Accessed February 3, 2022] https://dermnetnz.org/topics/pasi-score

Read next

How does Ilumya work to treat psoriasis?

Ilumya works by binding selectively to interleukin-23 (IL-23) which is a naturally occurring cytokine. IL-23 plays a key role in promoting inflammation and regulating other cytokines (such as IL-17) and inflammatory substances, such as TNF-α3-7. By blocking the effects of IL-23, Ilumya helps control the release of IL-17 and TNF-α, which reduces inflammation associated with psoriasis. It also decreases how many inflammatory cells are present within psoriatic lesions, helps prevent plaque formation, and resolves tissue damage. Continue reading

Prednisone: What are 12 Things You Should Know?

Prednisone first came onto the market over sixty years ago and is still going strong. But did you know that this common drug used for a variety of different conditions also has some pretty serious side effects as well? Continue reading

Where should you not use triamcinolone acetonide cream?

You should not use topical corticosteroids like triamcinolone acetonide cream on your face, groin, or axillae (underarm, armpit) unless directed by your doctor. Using triamcinolone in these areas may lead to unwanted side effects like acne, prominent blood vessels, skin thinning (atrophy), changes in skin color or unwanted hair growth. Continue reading

See also:

Related medical questions

Drug information

Related support groups